Stephanie Anzman-Frasca is an expert on childhood obesity with training in child development. She can speak to media about obesity risks and prevention and encouraging healthy eating habits in youth.

(RTTNews) - Prime Medicine, Inc.(PRME), Tuesday announced the initiation of its preclinical program for the treatment of Alpha-1 Antitrypsin Deficiency or AATD using its proprietary Prime Editing ...

(RTTNews) - Beam Therapeutics Inc. (BEAM) Monday reported positive initial data from its Phase 1/2 study of BEAM-302 for the treatment of alpha-1 antitrypsin deficiency (AATD). AATD is an ...